跳至主要内容
临床试验/CTRI/2025/08/093070
CTRI/2025/08/093070尚未招募Unknown

VISUAL AND REFRACTIVE OUTCOME OF INTRAOCULAR LENS CALCULATION IN SHORT EYES: HOFFER-Q VERSUS AI BASED KANE FORMULA A COMAPARATIVE STUDY : RANDOMISED CONTROL TRIAL

PriyankaPadarthi1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To compare the post operative refractive error accuracy of the Hoffer Q and Kane formulas in short eyes.

研究概览

简要总结

This randomized controlled trial compares the visual and refractive outcomes of intraocular lens (IOL) power calculation in short eyes (axial length <22 mm) using two different formulas: the traditional Hoffer Q formula and the AI-based Kane formula. Accurate IOL power prediction in short eyes remains a challenge due to anatomical variations. The study aims to evaluate which formula provides more precise postoperative visual outcomes, reduced refractive error, and overall better predictability in cataract surgery for short eyes.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Adults undergoing uneventful SICS with posterior chamber intraocular lens (IOL) implantation.
  • Axial length less than 22.0 mm as measured by A-scan biometry.
  • Willingness to participate and attend follow-up visits.

排除标准

  • Prior ocular surgery or trauma.
  • Intraoperative or postoperative complications.
  • Eyes with corneal opacities or irregular astigmatism..
  • Patients who have undergone refractive & retinal surgeries.

结局指标

主要结局

To compare the post operative refractive error accuracy of the Hoffer Q and Kane formulas in short eyes.

时间窗: At the time of discharge at day 1 postoperatively | At 1 week postoperatively | At 4 weeks postoperatively

次要结局

未报告次要终点

研究者

发起方
PriyankaPadarthi
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Priyanka Padarthi

mahatma gandhi medical college and research institute

研究点 (1)

Loading locations...

相似试验

COMPARING TWO METHODS TO IMPROVE VISION AFTER... | 临床试验